Studies showed that MYO5B (myosin VB) may become an important biomarker for gastric cancer because the expression of MYO5B was downregulated in gastric cancer and the inactivation of MYO5B may contribute to tumorigenesis [25]. The gene discussed is MYO5B; the disease is gastric cancer.